Colgate-Palmolive (NYSE:CL) Shares Bought by LGT Capital Partners LTD.

LGT Capital Partners LTD. lifted its position in Colgate-Palmolive (NYSE:CL - Free Report) by 2.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 991,390 shares of the company's stock after purchasing an additional 21,770 shares during the period. Colgate-Palmolive comprises 3.6% of LGT Capital Partners LTD.'s portfolio, making the stock its 9th largest holding. LGT Capital Partners LTD. owned approximately 0.12% of Colgate-Palmolive worth $102,916,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Price T Rowe Associates Inc. MD increased its holdings in Colgate-Palmolive by 27.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company's stock valued at $3,698,096,000 after acquiring an additional 8,933,912 shares during the last quarter. Swedbank AB bought a new stake in shares of Colgate-Palmolive in the first quarter worth about $286,370,000. Acadian Asset Management LLC boosted its stake in Colgate-Palmolive by 108.4% during the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company's stock valued at $551,367,000 after buying an additional 2,955,442 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in Colgate-Palmolive by 40.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company's stock valued at $870,400,000 after buying an additional 2,593,313 shares in the last quarter. Finally, Ossiam increased its stake in Colgate-Palmolive by 368.4% in the 1st quarter. Ossiam now owns 1,563,768 shares of the company's stock worth $140,817,000 after acquiring an additional 1,229,891 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Down 1.4 %

Shares of NYSE CL traded down $1.36 during trading hours on Tuesday, hitting $93.26. 2,325,497 shares of the stock were exchanged, compared to its average volume of 4,379,107. The company has a market cap of $76.19 billion, a PE ratio of 27.12, a PEG ratio of 3.34 and a beta of 0.42. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a fifty day moving average price of $99.06 and a 200-day moving average price of $98.55.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.50 dividend. The ex-dividend date was Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive's payout ratio is 57.31%.

Insider Buying and Selling

In other news, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 16.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The disclosure for this sale can be found here. 0.37% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CL has been the topic of several recent research reports. Piper Sandler initiated coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They set an "overweight" rating and a $121.00 target price on the stock. HSBC reiterated a "hold" rating on shares of Colgate-Palmolive in a report on Friday, July 26th. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Thursday, November 14th. Jefferies Financial Group cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and cut their price objective for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Finally, Stifel Nicolaus lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their target price for the stock from $105.00 to $101.00 in a report on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.